Form 8-K Vanda Pharmaceuticals For: Jul 27
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Oil settles up over $2 as Iran war stalemate stokes supply concerns
- Trump threatens to bomb Oman over Iran stance
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Vanda Pharmaceuticals (VNDA) Tops Q2 EPS by 12c
July 27, 2016 4:42 PM EDTVanda Pharmaceuticals (NASDAQ: VNDA) reported Q2 EPS of ($0.11), $0.12 better than the analyst estimate of ($0.23).
For earnings history and earnings-related data on Vanda Pharmaceuticals (VNDA) click here.
... More